Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Confirmation of Correct Tracheal Tube Placement in Newborn Infants - a Randomized Control Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01870622
Recruitment Status : Completed
First Posted : June 6, 2013
Last Update Posted : March 15, 2017
Sponsor:
Information provided by (Responsible Party):
University of Alberta

Brief Summary:
Most premature babies have difficulty breathing at birth and need help (resuscitation). The treatment for this is to gently inflate their lungs with a resuscitation device and a facemask. To gently inflate an infant's lungs the clinical team places a breathing tube in the windpipe and blow air into your baby's lung (puffs). With the first puffs the clinical team checks if the breathing tube is correctly placed within the windpipe. The investigators routinely use a detector which checks for exhaled carbon dioxide or the graphical display of waves forms of the infants breathing to check that the breathing tube position. However, the investigators do not know which one (exhaled carbon dioxide or the graphical display of waves forms) is better to check that the breathing tube position is correct and therefore the investigators would like to study them. The purpose of this study is to compare exhaled carbon dioxide detectors (ECO2 group) with the graphical display of waves forms (flow waves group) to provide us with information on how the investigators can help babies who struggle with breathing at birth.

Condition or disease Intervention/treatment Phase
Newborn Infant Procedure: Flow waves Procedure: ECO2 Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 100 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double (Investigator, Outcomes Assessor)
Primary Purpose: Diagnostic
Official Title: Confirmation of Correct Tracheal Tube Placement in Newborn Infants - a Randomized Control Trial
Study Start Date : June 2013
Actual Primary Completion Date : October 2014
Actual Study Completion Date : October 2014

Arm Intervention/treatment
Active Comparator: ECO2
ECO2 will be used to confirm correct tube placement in newborn infants.
Procedure: ECO2
ECO2 will be used to confirm correct tube placement in newborn infants.

Experimental: Flow waves
Flow waves will be used to confirm correct tube placement
Procedure: Flow waves
Flow waves will be used to confirm correct tube placement in newborn infants.




Primary Outcome Measures :
  1. Using flow waves will increase the percentage of correct tube placement in newborn infants [ Time Frame: within the first 10 inflations ]

    Flow waves and exhaled Carbon dioxide will be compared using the numbers of inflation needed to identify correct tube placement.

    We will compare the number of inflation in each group to identify which device can identify correct tube placement faster and more accurately.

    Outcome will be number of inflation until correct tube placement has been identified.




Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   up to 120 Days   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • All infants (term and preterm) born at The Royal Alexandra Hospital who require endotracheal intubation in the delivery room or neonatal intensive care unit will be recorded.

Exclusion Criteria:

  • Infants will also be excluded if their parents refuse to give consent to this study.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01870622


Locations
Layout table for location information
Canada, Alberta
Royal Alexandra Hospital
Edmonton, Alberta, Canada, T5H 3V9
Sponsors and Collaborators
University of Alberta
Publications:

Layout table for additonal information
Responsible Party: University of Alberta
ClinicalTrials.gov Identifier: NCT01870622    
Other Study ID Numbers: Pro00036974
First Posted: June 6, 2013    Key Record Dates
Last Update Posted: March 15, 2017
Last Verified: March 2017
Keywords provided by University of Alberta:
Newborn,
Infant,
Endotracheal Intubation,
Carbon dioxide detector,
Flow waves